PFEPfizer

Median target
$28
calls from the last 12 months
Implied return
+1.3%
median target vs. price
Coverage
26 analysts · 30 calls
updated in the last 12 months
Consensus
8/16/2+6 net
Buy / Hold / Sell

Which analysts are behind PFE's consensus?

See every current rating, price target and the analysts' track records for Pfizer — plus the full analyst rankings, firm analytics and screener.

The consensus above reflects 26 analysts with calls on PFE updated in the last 12 months. Implied return is the move implied if the consensus target were hit. These are forward-looking predictions, not realized returns. Per-analyst ratings and track records are a Premium feature.

PFE elsewhere on AnalystEdge

The most recent congressional, executive-branch and insider filings matched to this ticker. Matched by ticker symbol — occasional mismatches are possible. Not investment advice.

Trending today: not in any of today's trending tables (Gaining attention, Losing attention, Most followed)

DateSourceWhoActionDetailAmount
2026-08-12InsidersBourla AlbertChairman & CEOInsider purchase38.0K sh @ $26.34$1.0M
2026-08-05InsidersBlaylock Ronald EDirectorInsider purchase39.2K sh @ $25.46$999K
2026-08-05InsidersBuckley Mortimer JDirectorInsider purchase37.6K sh @ $25.52$960K
2026-08-05InsidersDamico Jennifer B.SVP & ControllerInsider sale3.3K sh @ $25.40$83K
2026-03-02ExecutiveTrump, Donald JPresidentTransactionPFIZER INC$15,001 - $50,000
2026-02-10CongressGilbert CisnerosCA-CA39Purchasesince trade +3.6%, vs market -6.7%$1K–$15K
2025-12-31CongressJames French HillAR-AR02Salesince trade +16.8%, vs market -4.8%$100K–$250K
2025-12-29ExecutiveTrump, Donald JPresidentPurchasePfizer Inc$100,001 - $250,000
2025-12-19CongressGilbert CisnerosCA-CA39Salesince trade +15.5%, vs market -3.3%$1K–$15K
2025-12-12ExecutiveTrump, Donald JPresidentPurchasePFIZER INC$1,001 - $15,000

More: congressional trades on PFE · insider activity · executive branch · trending